Melatonin improves sleep-wake patterns in psychomotor retarded children

Area of Science:

• Pediatric Neurology
• Sleep Medicine
• Developmental Pediatrics

Background:

• Children with severe psychomotor retardation often exhibit irregular sleep-wake patterns.
• Abnormally low urinary sulfatoxymelatonin levels, with no diurnal variation, were observed in these children.
• This suggests a potential disruption in endogenous melatonin production or regulation.

Purpose of the Study:

• To investigate the efficacy of melatonin supplementation in improving sleep-wake patterns in children with severe psychomotor retardation.
• To assess the impact of melatonin on nighttime and daytime sleep duration and overall sleep efficiency.
• To evaluate changes in sleep patterns following a standardized melatonin treatment regimen.

Main Methods:

• Five children with severe psychomotor retardation (mean age 8.2 years) were monitored using wrist actigraphy for one week.
• Participants received a 3 mg dose of melatonin daily.
• Actigraphy was repeated after the treatment period, and urinary sulfatoxymelatonin levels were measured in three participants.

Main Results:

• Melatonin treatment significantly increased nighttime sleep duration (from 5.9 to 7.3 hours, P<0.01).
• Sleep efficiency improved significantly from 69.3% to 88.3% (P<0.01).
• Daytime sleep duration decreased (from 3.2 to 1.7 hours, P<0.05), with no significant change in total 24-hour sleep time.

Conclusions:

• Administration of 3 mg melatonin effectively improved sleep-wake patterns in children with severe psychomotor retardation.
• Melatonin supplementation can be a beneficial therapeutic option for managing sleep disturbances in this population.
• Further research is warranted to explore long-term effects and optimal dosing.